Kenzie MacIsaac
Partner at Cure Ventures
About
A drug discovery professional with over 13 years of experience in genetics, genomics, and bioinformatics. Held senior roles at Bristol Myers Squibb, Fog Pharma, Novartis, and Merck, building oncology precision medicine capabilities and leading bioinformatics platforms. Holds PhD in computer science from MIT.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures